The best indicator for Moderna (MRNA)
We backtested 382 indicators across daily, weekly and hourly charts on real Moderna (MRNA) history. Here's what actually worked — risk-adjusted over the full backtest, with costs, and checked out-of-sample.
Where Moderna (MRNA) stands
Computed from our own daily OHLCV history, not quoted from a third party. Moving averages use closing prices; "52-week" is the last 252 trading sessions.
Stoch RSI (fast)
On the daily chart, this is the strongest risk-adjusted edge we found for Moderna (MRNA) over ~7.8 years — beating buy-and-hold by 20.3% CAGR.
Moderna (MRNA) on the daily chart
The timeframe our backtest found best for this asset. The chart is live market data; the results above are hypothetical and historical.
Chart by TradingView. Loading it contacts tradingview.com, which may set its own cookies — see our privacy policy.
Best multi-indicator combo
Going long only when all 2 agree was the strongest confluence setup we found for Moderna (MRNA) — beating buy-and-hold by 34.2% CAGR, out-of-sample. Fewer, higher-conviction trades than any single indicator.
The winner on each chart
Every indicator, ranked
Ranked by Sharpe (risk-adjusted return). Hypothetical, fees included.
| # | Indicator | TF | CAGR | Sharpe | Max DD | Win | Trades | vs B&H |
|---|---|---|---|---|---|---|---|---|
| 1 | Stoch RSI (fast) ✓ | Daily | 56.2% | 1.1 | -62.9% | 44.7% | 199 | 20.3% |
| 2 | Chande Forecast Osc. ✓ | Daily | 50.2% | 1.03 | -59.8% | 50.5% | 208 | 14.2% |
| 3 | Ehlers SuperSmoother ✓ | Daily | 49.8% | 1.01 | -65.2% | 45.5% | 246 | 13.8% |
| 4 | Fisher Transform | Daily | 48.2% | 0.99 | -81.1% | 44.8% | 183 | 12.2% |
| 5 | Ehlers Cyber Cycle ✓ | Daily | 45.7% | 0.96 | -70.2% | 48.4% | 190 | 9.7% |
| 6 | Force Index ✓ | Weekly | 63.7% | 0.95 | -67.8% | 50.0% | 18 | 29.1% |
| 7 | HMA 9/21 Cross ✓ | Daily | 72.3% | 0.94 | -55.5% | 49.2% | 132 | 36.4% |
| 8 | Kaufman Adaptive MA ✓ | Weekly | 60.8% | 0.93 | -51.4% | 60.0% | 20 | 26.2% |
| 9 | Disparity Index ✓ | Weekly | 60.3% | 0.93 | -43.2% | 47.6% | 21 | 25.7% |
| 10 | Pretty Good Oscillator ✓ | Weekly | 59.5% | 0.93 | -43.2% | 50.0% | 20 | 24.9% |
| 11 | Center of Gravity ✓ | Daily | 40.6% | 0.91 | -72.1% | 47.1% | 225 | 4.6% |
| 12 | Chande-Kroll Stop (fast) ✓ | Daily | 68.7% | 0.91 | -86.0% | 39.9% | 153 | 32.7% |
| 13 | VIDYA 30 Trend ✓ | Daily | 68.0% | 0.91 | -64.3% | 50.0% | 32 | 32.1% |
| 14 | Momentum ✓ | Weekly | 59.0% | 0.91 | -49.7% | 52.4% | 21 | 24.4% |
✓ = held up out-of-sample. Hypothetical, costs included. See methodology.
The question doesn't apply here. Buy-and-hold on Moderna (MRNA) lost money across the out-of-sample window in 349 of 349 tests, so there is no positive benchmark to lever toward — clearing a negative bar is a much weaker claim than beating a real one, and we keep the two apart rather than counting it as a win. How we compute that
For Moderna (MRNA), Stoch RSI (fast) on the daily timeframe gave the best balance of return and risk in our test. It beat buy-and-hold — but remember: this is a hypothetical backtest of a standard rule, not a recommendation. Markets change. See the methodology and disclaimer.
More stock
Get alerted when Moderna’s signal flips
We track Moderna daily. Its backtested best indicator, Stoch RSI (fast) (Daily), is flat right now — we'll email you the moment that changes. Free, no spam, unsubscribe any time.